Crystallography

Eli Lilly to acquire SGX Pharmaceuticals for $64 million (PharmaBiz)

9 Jul 2008

Eli Lilly and Company and SGX Pharmaceuticals, Inc. announced that the companies have signed a definitive merger agreement providing for the acquisition of SGX in an all-cash transaction.

Eli Lilly to buy SGX Pharmaceuticals (News-Medical-Net)

9 Jul 2008

Eli Lilly and Company and SGX Pharmaceuticals, Inc. today announced that the companies have signed a definitive merger agreement providing for the acquisition of SGX in an all-cash transaction. SGX, based in San Diego, California, is a biotechnology company focused on drug discovery and development in the area of oncology.

From Staff Reports (BioWorld)

9 Jul 2008

Shares of SGX Pharmaceuticals Inc. hit an all-time low in March when the company reported unexpected toxicity in two Phase I trials of compound SGX-523 in patients with solid tumor cancers.